Cantitate/Preț
Produs

Pharmacologic Therapy of Ocular Disease: Handbook of Experimental Pharmacology, cartea 242

Editat de Scott M. Whitcup, Dimitri T. Azar
en Limba Engleză Hardback – 16 iun 2017
There have been major advancements in the pharmacologic treatment of eye diseases over the past decade. With newly discovered disease targets and novel approaches to deliver therapeutic compounds to the eye, patients are seeing improved outcomes. Not only are there better treatments for diseases where treatments existed, we now have effective therapy for previously untreatable and blinding eye disorders. This volume will cover the pharmacologic treatment of eye diseases from the front of the eye including eyelids, conjunctiva and cornea all the way back to the retina and optic nerve. The first section of the volume reviews general principles of ocular pharmacology, pharmacokinetics, pharmaceutical sciences, and drug delivery. In addition, the volume provides an up to date guide to the pharmacologic approach to the key eye diseases that threaten sight or ocular function.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 193592 lei  38-44 zile
  Springer International Publishing – 4 aug 2018 193592 lei  38-44 zile
Hardback (1) 207690 lei  3-5 săpt.
  Springer International Publishing – 16 iun 2017 207690 lei  3-5 săpt.

Din seria Handbook of Experimental Pharmacology

Preț: 207690 lei

Preț vechi: 218621 lei
-5% Nou

Puncte Express: 3115

Preț estimativ în valută:
39748 41287$ 33016£

Carte disponibilă

Livrare economică 11-25 ianuarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783319582887
ISBN-10: 3319582887
Pagini: 394
Ilustrații: VIII, 394 p.
Dimensiuni: 155 x 235 mm
Greutate: 0.82 kg
Ediția:1st ed. 2017
Editura: Springer International Publishing
Colecția Springer
Seria Handbook of Experimental Pharmacology

Locul publicării:Cham, Switzerland

Cuprins

General Principles: Principles of Ocular Pharmacology.- Ocular Pharmacokinetics.- Ocular Drug Delivery.- Anterior Segment and Tear Film: Tear Film-dry eye.- Conjunctiva-allergic conjunctivitis, infectious conjunctivitis, conjunctival hyperemia .- Cornea-Keratitis, antibiotics, antifungals, anti-virals, anti-inflammatory agents including corticosteroids and NSAIDS.- Cornea-Keratoconus and other corneal disease, Pharmacologic cross-linking and future therapy.- Lens-management of cataract surgery, cataract prevention, floppy iris syndrome.- Trabecular Meshwork and Uvea: Glaucoma-Intraocular Pressure Reduction.- Glaucoma-Neuroprotection .- Uveitis.- Posterior Segment and Optic Nerve: Retina Anti-angiogenesis, AMD, Myopia, DME.- Retina Anti-inflammatory therapy, corticosteroids, anti-complement, AMD, DME.- Atrophic AMD.- Hereditary Retinal Disease .- Optic Nerve.

Caracteristici

Current review of the basic principles of ocular pharmacology, pharmacokinetics, and drug delivery including novel approaches to delivering compounds to the eye like sustained-release implants, cell therapy, and gene therapy Review of existing and future therapies for ocular diseases from the eye lids to the optic nerve Discussion of potential adverse effects of pharmacologic treatments and limitationof side effects in the treatment of ocular disease Includes supplementary material: sn.pub/extras Includes supplementary material: sn.pub/extras